Brainsway Ltd (BWAY)

Currency in USD
15.23
-0.02(-0.13%)
Closed·
15.230.00(0.00%)
·
Advertisement
Earnings results expected in 11 days
BWAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.8215.72
52 wk Range
5.7017.35
Key Statistics
Prev. Close
15.25
Open
15.71
Day's Range
14.82-15.72
52 wk Range
5.7-17.35
Volume
179.58K
Average Volume (3m)
130.88K
1-Year Change
165.5623%
Book Value / Share
1.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BWAY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.67
Upside
+16.00%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Brainsway Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 17.67
(+16.00% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy17.00+11.62%-Maintain24/07/2026
BTIG
Buy18.00+18.19%-New Coverage20/07/2026
H.C. Wainwright
Buy14.00-8.08%-Maintain17/07/2026
H.C. Wainwright
Buy17.00+11.62%-Maintain17/07/2026
H.C. Wainwright
Buy17.00+11.62%-Maintain02/07/2026

Earnings

Latest Release
13/05/2026
EPS / Forecast
0.06 / 0.03
Revenue / Forecast
15.5M / 14.31M
EPS Revisions
Last 90 days

Compare BWAY to Peers and Sector

Metrics to compare
BWAY
Peers
Sector
Relationship
P/E Ratio
73.3x−0.6x−0.3x
PEG Ratio
0.41−0.030.00
Price/Book
8.5x3.6x2.6x
Price / LTM Sales
11.4x3.3x3.0x
Upside (Analyst Target)
18.2%59.7%56.7%
Fair Value Upside
Unlock13.4%9.4%Unlock

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.09M12.70%77.54M
Other Institutional Investors
11.25M28.07%171.38M
Public Companies & Retail Investors
23.74M59.23%361.61M
Total
40.09M100.00%610.53M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Valor Management LLC13.26%5,314,95080,947
Masters Capital Management, L.L.C.4.12%1,650,00025,130

People Also Watch

123.08
NWPX
-2.99%
7.210
CVV
+10.75%
87.46
ALNT
+1.45%
3.41
VRA
-2.29%
60.430
AXTI
+28.74%

FAQ

What Is the Brainsway (NASDAQ: BWAY) Share Price Today?

The Brainsway stock price today is 15.23 USD.

What Stock Exchange Does Brainsway (BWAY) Trade On?

Brainsway is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Brainsway?

The stock symbol (also called a 'ticker') for Brainsway is "BWAY."

What Is the Current Brainsway Market Capitalisation?

As of today, Brainsway (NASDAQ: BWAY) market cap is 642.85M USD.

What Is Brainsway's (BWAY) Earnings Per Share (TTM)?

The Brainsway EPS is currently 0.22 (Trailing Twelve Months).

When Is the Next Brainsway Earnings Date?

Brainsway's next earnings report will be released on 12/08/2026.

Is BWAY a Buy or Sell From a Technical Analyst Perspective?

Based on today's Brainsway moving averages and other technical indicators, the daily buy/sell signal for BWAY stock is Neutral.

How Many Times Has Brainsway Stock Split?

Brainsway has split 1 times. (See the BWAY stock split history page for full effective split date and price information.)

How Many Employees Does Brainsway Have?

Brainsway has 129 employees, based on their latest Companies House report.

What is the current trading status of Brainsway (NASDAQ: BWAY)?

As of 01/08/2026, Brainsway (BWAY) is trading at a share price of 15.23 USD, with a previous close of 15.25 USD. The stock has fluctuated within a day range of 14.82 USD to 15.72 USD, while its 52-week range spans from 5.70 USD to 17.35 USD.

What Is Brainsway (BWAY) Price Target According to Analysts?

The average 12-month price target for Brainsway is 17.67 USD, with a high estimate of 18 USD and a low estimate of 17 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +16.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.